Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Outside Co-Investigators include Kate Rendle, PhD, National Cancer Institute, and Allison Kurian, MD, Stanford University School of Medicine.
Stanford University (California Breast Cancer Research Program and the Richard and Susan Levy Fund)
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Primary and Secondary Prevention of Osteoporosis-Related Fracture: The Use of DEXA and FRAX Results in a Community–based Practice
Investigator: Su-Ying Liang, Ph.D.